137 related articles for article (PubMed ID: 35931032)
1. Direct chemical reprogramming of human cord blood erythroblasts to induced megakaryocytes that produce platelets.
Qin J; Zhang J; Jiang J; Zhang B; Li J; Lin X; Wang S; Zhu M; Fan Z; Lv Y; He L; Chen L; Yue W; Li Y; Pei X
Cell Stem Cell; 2022 Aug; 29(8):1229-1245.e7. PubMed ID: 35931032
[TBL] [Abstract][Full Text] [Related]
2. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y
PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264
[TBL] [Abstract][Full Text] [Related]
3. ABCC4 impacts megakaryopoiesis and protects megakaryocytes against 6-mercaptopurine induced cytotoxicity.
Ranjit S; Wang Y; Zhu J; Cheepala SB; Schuetz EG; Cho WJ; Xu B; Robinson CG; Wu G; Naren AP; Schuetz JD
Drug Resist Updat; 2024 Jan; 72():101017. PubMed ID: 37988981
[TBL] [Abstract][Full Text] [Related]
4. Transdifferentiation of erythroblasts to megakaryocytes using FLI1 and ERG transcription factors.
Siripin D; Kheolamai P; U-Pratya Y; Supokawej A; Wattanapanitch M; Klincumhom N; Laowtammathron C; Issaragrisil S
Thromb Haemost; 2015 Aug; 114(3):593-602. PubMed ID: 26063314
[TBL] [Abstract][Full Text] [Related]
5. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release.
Mattia G; Vulcano F; Milazzo L; Barca A; Macioce G; Giampaolo A; Hassan HJ
Blood; 2002 Feb; 99(3):888-97. PubMed ID: 11806991
[TBL] [Abstract][Full Text] [Related]
6. Good Manufacturing Practice-Grade of Megakaryocytes Produced by a Novel Ex Vivo Culturing Platform.
Guan X; Wang L; Wang H; Wang H; Dai W; Jiang Y
Clin Transl Sci; 2020 Nov; 13(6):1115-1126. PubMed ID: 33030809
[TBL] [Abstract][Full Text] [Related]
7. Baffled-flow culture system enables the mass production of megakaryocytes from human embryonic stem cells by enhancing mitochondrial function.
Wu X; Zhang B; Chen K; Zhao J; Li Y; Li J; Liu C; He L; Fan T; Wang C; Li Y; Pei X; Li Y
Cell Prolif; 2023 Dec; 56(12):e13484. PubMed ID: 37088551
[TBL] [Abstract][Full Text] [Related]
8. Augmented Production of Platelets From Cord Blood With Euchromatic Histone Lysine Methyltransferase Inhibition.
Liu Y; Zhao J; Wang Y; Su P; Wang H; Liu C; Zhou J
Stem Cells Transl Med; 2022 Sep; 11(9):946-958. PubMed ID: 35880582
[TBL] [Abstract][Full Text] [Related]
9. Megakaryocyte- and erythroblast-specific cell-free DNA patterns in plasma and platelets reflect thrombopoiesis and erythropoiesis levels.
Moss J; Ben-Ami R; Shai E; Gal-Rosenberg O; Kalish Y; Klochendler A; Cann G; Glaser B; Arad A; Shemer R; Dor Y
Nat Commun; 2023 Nov; 14(1):7542. PubMed ID: 37985773
[TBL] [Abstract][Full Text] [Related]
10. Megakaryocyte-induced contraction of plasma clots: cellular mechanisms and structural mechanobiology.
Kim OV; Litvinov RI; Gagne AL; French DL; Brass LF; Weisel JW
Blood; 2024 Feb; 143(6):548-560. PubMed ID: 37944157
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand.
Cramer EM; Norol F; Guichard J; Breton-Gorius J; Vainchenker W; Massé JM; Debili N
Blood; 1997 Apr; 89(7):2336-46. PubMed ID: 9116277
[TBL] [Abstract][Full Text] [Related]
12. In vitro biological characteristics of human cord blood-derived megakaryocytes.
Sun L; Tan P; Yap C; Hwang W; Koh LP; Lim CK; Aw SE
Ann Acad Med Singap; 2004 Sep; 33(5):570-5. PubMed ID: 15531951
[TBL] [Abstract][Full Text] [Related]
13. Efficient generation of megakaryocytes from human induced pluripotent stem cells using food and drug administration-approved pharmacological reagents.
Liu Y; Wang Y; Gao Y; Forbes JA; Qayyum R; Becker L; Cheng L; Wang ZZ
Stem Cells Transl Med; 2015 Apr; 4(4):309-19. PubMed ID: 25713465
[TBL] [Abstract][Full Text] [Related]
14. Identifying and enriching platelet-producing human stem cell-derived megakaryocytes using factor V uptake.
Sim X; Jarocha D; Hayes V; Hanby HA; Marks MS; Camire RM; French DL; Poncz M; Gadue P
Blood; 2017 Jul; 130(2):192-204. PubMed ID: 28455282
[TBL] [Abstract][Full Text] [Related]
15. Megakaryocyte and platelet production from human cord blood stem cells.
Robert A; Cortin V; Garnier A; Pineault N
Methods Mol Biol; 2012; 788():219-47. PubMed ID: 22130711
[TBL] [Abstract][Full Text] [Related]
16. Infused factor VIII-expressing platelets or megakaryocytes as a novel therapeutic strategy for hemophilia A.
Lyde RB; Ahn HS; Vo KK; Jarocha DJ; Tkaczynski J; Treffeisen E; Sullivan SK; Camire RM; Sabatino DE; French DL; Poncz M
Blood Adv; 2019 May; 3(9):1368-1378. PubMed ID: 31036722
[TBL] [Abstract][Full Text] [Related]
17. Modulation of megakaryopoiesis and platelet production during inflammation.
Couldwell G; Machlus KR
Thromb Res; 2019 Jul; 179():114-120. PubMed ID: 31128560
[TBL] [Abstract][Full Text] [Related]
18. Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells.
Perdomo J; Yan F; Leung HHL; Chong BH
J Vis Exp; 2017 Dec; (130):. PubMed ID: 29364213
[TBL] [Abstract][Full Text] [Related]
19. In vitro large scale production of megakaryocytes to functional platelets from human hematopoietic stem cells.
Kumar PS; Chandrasekhar C; Srikanth L; Sarma PVGK
Biochem Biophys Res Commun; 2018 Oct; 505(1):168-175. PubMed ID: 30243726
[TBL] [Abstract][Full Text] [Related]
20. In vitro generation of platelets through direct conversion: first report in My Knowledge (iMK).
Masuda S; Li M; Izpisua Belmonte JC
Cell Res; 2013 Feb; 23(2):176-8. PubMed ID: 23044804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
